| Financial Year |
March 31 2023 |
| Monetary Funds |
210,601,008.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
138,973,054.84 |
| Accounts Receivable |
307,328,955.59 |
| Advances to Suppliers |
51,311,470.21 |
| Other Receivables |
13,443,787.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
200,872,720.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,095,979.78 |
| Total Current Assets |
942,255,202.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
974,289.78 |
| Fixed Assetes |
301,782,338.43 |
| Under-construction Projects |
26,508,240.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,136,776.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,635,100.70 |
| Deferred Income Tax Assets |
79,287,837.79 |
| Other Non-Current Assets |
39,972,240.96 |
| Sub-Total of Non-Current Assets |
525,358,856.03 |
| Total Assets |
1,467,614,058.76 |
| Short-Term Loans |
569,693,690.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,786,062.16 |
| Accounts Payable |
74,957,834.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,851,870.73 |
| Taxes Payable |
3,341,808.96 |
| Interest Payable |
1,045,098.18 |
| Dividend Payable |
-- |
| Other payables |
23,083,054.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
660,000.00 |
| Other Current Liabilities |
23,496,972.32 |
| Sub-Total of Current Liabilities |
797,271,537.60 |
| Long-term Loans |
1,102,274.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,350,019.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,801,188.94 |
| Total Liabilities |
822,072,726.54 |
| Paid-In Capital(Or Share Stock) |
289,209,902.00 |
| Capital Surplus |
359,703,074.01 |
| Surplus Reserve |
566,188.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-54,542,433.39 |
| Minority Stockholder's Interest |
12,210,875.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
633,330,456.69 |
| Owner's Equity（Stockholder's Equity） |
645,541,332.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,467,614,058.76 |
